top of page
eduo
visual
Add a Title
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Core Principle of Choledocholithiasis
Choledocholithiasis is the presence of gallstones within the common bile duct (CBD), occurring in 10-15% of patients with cholelithiasis.
Stones can migrate from the gallbladder through the cystic duct or form de novo within the CBD (primary bile duct stones, more common in Asia).
CBD obstruction causes upstream biliary dilation, cholestasis, and creates a nidus for ascending bacterial infection (cholangitis).
The clinical triad of RUQ pain, jaundice, and fever suggests choledocholithiasis with cholangitis — a medical emergency requiring urgent decompression.
Pathophysiology of Bile Duct Obstruction
Stone impaction at the ampulla of Vater obstructs bile flow → conjugated hyperbilirubinemia, dark urine (water-soluble conjugated bilirubin), and pale stools (absent bile pigments).
Elevated intrabiliary pressure causes hepatocyte injury → transaminase elevation (usually <1000 U/L).
Chronic obstruction leads to bile salt deposition in skin → pruritus.
Board pearl: Unlike hepatocellular jaundice, obstructive jaundice presents with disproportionately elevated alkaline phosphatase and direct bilirubin relative to transaminases.
Laboratory Pattern Recognition
Cholestatic pattern: alkaline phosphatase and GGT elevation >> transaminase elevation.
Direct (conjugated) hyperbilirubinemia predominates — typically >50% of total bilirubin.
Transient transaminase spike (AST/ALT >1000) can occur with acute obstruction, then rapidly decline.
Elevated WBC suggests cholangitis; normal WBC doesn't exclude uncomplicated choledocholithiasis.
Board clue: Fluctuating bilirubin levels suggest intermittent obstruction from a ball-valve stone.
Clinical Presentation Spectrum
Asymptomatic: incidental finding on imaging or intraoperative cholangiogram.
Biliary colic: episodic RUQ pain without fever or jaundice — stone causing intermittent obstruction.
Obstructive jaundice: persistent RUQ pain with jaundice, dark urine, pale stools.
Ascending cholangitis: Charcot's triad (RUQ pain + jaundice + fever) or Reynolds' pentad (triad + altered mental status + hypotension).
Board distinction: Painless jaundice suggests malignancy; painful jaundice suggests stone disease.
Ultrasound as First-Line Imaging
Ultrasound is the initial imaging modality — non-invasive, no radiation, readily available.
Directly visualizes CBD stones in only 50% of cases due to overlying bowel gas.
Indirect signs are more sensitive: CBD dilation (>6mm, or >8mm post-cholecystectomy), intrahepatic biliary dilation.
Concurrent findings: gallbladder stones, wall thickening, pericholecystic fluid.
Board pearl: Normal ultrasound does not exclude choledocholithiasis — proceed to MRCP or EUS if clinical suspicion remains high.
MRCP: The Non-Invasive Gold Standard
Magnetic resonance cholangiopancreatography (MRCP) has 95% sensitivity and specificity for CBD stones.
T2-weighted sequences show bile as bright signal; stones appear as filling defects.
Provides detailed biliary anatomy without contrast or radiation.
Limitations: claustrophobia, metal implants, inability to perform therapeutic intervention.
Board pearl: MRCP is preferred over ERCP for diagnosis when probability of CBD stone is intermediate (10-50%).
ERCP: Diagnostic and Therapeutic
Endoscopic retrograde cholangiopancreatography allows direct visualization and stone extraction.
Indications: high probability of CBD stone (>50%), cholangitis requiring urgent decompression, failed medical management.
Therapeutic options: sphincterotomy, balloon extraction, basket retrieval, lithotripsy for large stones.
Complications: pancreatitis (5%), bleeding, perforation, cholangitis.
Board pearl: ERCP without prior imaging is justified only in cholangitis or very high clinical suspicion.
Endoscopic Ultrasound (EUS)
EUS has sensitivity comparable to MRCP but is invasive, requiring conscious sedation.
Advantage: can proceed immediately to ERCP if stone detected (same sedation session).
Particularly useful for small stones (<5mm) that MRCP might miss.
Can evaluate ampullary pathology and perform FNA of periampullary masses.
Board distinction: Choose EUS over MRCP when ERCP is likely needed anyway (high pre-test probability).
Risk Stratification for CBD Stones
High risk (>50% probability): CBD stone on imaging, bilirubin >4 mg/dL, dilated CBD on ultrasound, ascending cholangitis.
Intermediate risk (10-50%): age >55, abnormal LFTs other than bilirubin, clinical gallstone pancreatitis.
Low risk (<10%): normal LFTs, no CBD dilation, no clinical suspicion.
Board pearl: Risk stratification determines diagnostic approach — high risk → ERCP; intermediate → MRCP/EUS; low → observe.
Cholangitis: A Medical Emergency
Ascending cholangitis results from bacterial translocation across obstructed biliary epithelium.
Common organisms: E. coli, Klebsiella, Enterococcus, Enterobacter — gut flora ascending from duodenum.
Charcot's triad present in 50-70%; Reynolds' pentad indicates septic shock.
Immediate management: IV fluids, broad-spectrum antibiotics (covering gram-negatives and anaerobes), urgent ERCP.
Board pearl: Cholangitis is the only biliary emergency requiring immediate intervention — not cholecystitis.
Timing of Intervention
Cholangitis: urgent ERCP within 24 hours (within 12 hours if severe sepsis).
Uncomplicated choledocholithiasis: ERCP during same admission, ideally within 48-72 hours.
Gallstone pancreatitis with CBD stone: ERCP within 48 hours if cholangitis; otherwise after pancreatitis improves.
Post-cholecystectomy CBD stone: elective ERCP unless symptomatic.
Board distinction: Only cholangitis requires emergent intervention; other presentations allow time for optimization.
Gallstone Pancreatitis Crossover
CBD stones can obstruct the pancreatic duct at the ampulla → acute pancreatitis.
Transient obstruction may pass spontaneously — explains why CBD stone isn't always found on imaging.
Persistent elevation of ALT >3× upper limit suggests ongoing biliary obstruction.
Early ERCP indicated only if concurrent cholangitis or persistent obstruction.
Board pearl: Declining bilirubin and improving pain suggest stone passage — ERCP may not be needed.
Post-Cholecystectomy Syndrome
Recurrent biliary-type pain after cholecystectomy occurs in 10-15% of patients.
Causes: retained CBD stone, biliary dyskinesia, sphincter of Oddi dysfunction, functional pain.
Retained stones can present months to years post-operatively.
Evaluation: LFTs, ultrasound for CBD dilation, MRCP if suspicion remains.
Board clue: Dilated CBD >8mm after cholecystectomy is abnormal and suggests obstruction.
Primary vs Secondary CBD Stones
Secondary stones (85%): migrate from gallbladder, composed of cholesterol or black pigment.
Primary stones (15%): form de novo in bile ducts, usually brown pigment stones from bacterial deconjugation of bilirubin.
Primary stones associated with biliary stasis: strictures, parasites (Clonorchis), recurrent pyogenic cholangitis.
Geographic pearl: Primary CBD stones are endemic in East Asia due to liver fluke infection.
Mirizzi Syndrome
Large stone in gallbladder neck or cystic duct causes extrinsic compression of common hepatic duct.
Presents like choledocholithiasis but stone is outside the bile duct.
Chronic inflammation can create cholecystocholedochal fistula.
MRCP shows the stone location and ductal anatomy.
Board pearl: Mirizzi syndrome contraindications ERCP sphincterotomy — requires surgical management.
Recurrent Pyogenic Cholangitis
Endemic in East Asia, associated with parasitic infections and primary CBD stones.
Recurrent episodes of cholangitis lead to strictures, intrahepatic stone formation, and biliary cirrhosis.
Imaging shows intrahepatic ductal dilation with stones, hepatic abscesses.
Treatment requires antibiotics, biliary drainage, and often hepatic resection.
Board clue: Asian patient with recurrent cholangitis and intrahepatic stones → suspect parasitic etiology.
Pregnancy Considerations
Choledocholithiasis is the second most common cause of jaundice in pregnancy (after viral hepatitis).
Ultrasound remains first-line; MRCP safe in second/third trimester.
ERCP with lead shielding can be performed if necessary — risk of cholangitis outweighs radiation exposure.
Cholecystectomy during second trimester for symptomatic stones reduces risk of recurrent biliary complications.
Board pearl: Pregnancy doesn't contraindicate necessary biliary intervention — untreated cholangitis risks fetal loss.
Complications of Untreated Choledocholithiasis
Acute cholangitis → sepsis, hepatic abscesses, death if untreated.
Chronic obstruction → secondary biliary cirrhosis.
Acute pancreatitis from ampullary stone.
Cholangiocarcinoma risk increased with chronic inflammation.
Biliary-enteric fistula from pressure necrosis.
Board distinction: Unlike cholecystitis, choledocholithiasis complications are systemic and life-threatening.
Board Question Stem Patterns
RUQ pain + jaundice + dilated CBD on ultrasound → choledocholithiasis until proven otherwise.
Cholestatic LFTs + fever + RUQ pain → cholangitis, requires urgent ERCP.
Post-cholecystectomy patient with new jaundice → retained CBD stone.
Fluctuating bilirubin with biliary colic → intermittent CBD obstruction.
Asian patient with intrahepatic stones and recurrent cholangitis → primary hepatolithiasis.
Gallstone pancreatitis with persistent LFT elevation → ERCP to clear CBD.
Normal ultrasound but high clinical suspicion → proceed to MRCP, not observation.
One-Line Recap
Choledocholithiasis causes obstructive jaundice with a cholestatic pattern (↑ALP > ↑AST/ALT), diagnosed by ultrasound showing CBD dilation or MRCP visualizing stones, requiring ERCP for stone extraction — urgently if complicated by ascending cholangitis (Charcot's triad), or electively for uncomplicated cases.
bottom of page